{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:23:30Z","timestamp":1794781410766,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA039073"],"award-info":[{"award-number":["R01DA039073"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R37DA019829"],"award-info":[{"award-number":["R37DA019829"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugpo.2017.05.050","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T01:01:59Z","timestamp":1500339719000},"page":"156-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":218,"special_numbering":"C","title":["Today\u2019s fentanyl crisis: Prohibition\u2019s Iron Law, revisited"],"prefix":"10.1016","volume":"46","author":[{"given":"Leo","family":"Beletsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.05.050_bib0005","series-title":"Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. National Bureau of Economic research working paper 23031","author":"Alpert","year":"2017"},{"issue":"18","key":"10.1016\/j.drugpo.2017.05.050_bib0010","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2012.14205","article-title":"Prevention of fatal opioid overdose","volume":"308","author":"Beletsky","year":"2012","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0015","first-page":"155","article-title":"Fatal re-entry: Legal and programmatic opportunities to curb opioid overdose among individuals newly released from incarceration","volume":"7","author":"Beletsky","year":"2015","journal-title":"Northeastern University Law Journal"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.050_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10826089609045806","article-title":"Methadone maintenance and addicts\u2019 risk of fatal heroin overdose","volume":"31","author":"Caplehorn","year":"1996","journal-title":"Substance Use & Misuse"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.050_bib0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: A retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0030","first-page":"26","article-title":"How the narcs created crack","volume":"38","author":"Cowan","year":"1986","journal-title":"National Review"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2016.04.002","article-title":"Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements","volume":"163","author":"Davis","year":"2016","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18060\/3911.0027","article-title":"The law and policy of opioids for pain management, addiction, treatment, and overdose reversal","volume":"14","author":"Davis","year":"2017","journal-title":"Indiana Health Law Review"},{"issue":"S1","key":"10.1016\/j.drugpo.2017.05.050_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1073110517703310","article-title":"Action, not rhetoric, needed to reverse the opioid overdose epidemic","volume":"45","author":"Davis","year":"2017","journal-title":"The Journal of Law, Medicine & Ethics"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0050","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain-United States","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0055","series-title":"National drug threat assessment summary, US Department of Justice (Washington, DC)","author":"Drug Enforcement Administration","year":"2016"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs","author":"Gellad","year":"2017","journal-title":"JAMA Internal Medicine"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.050_bib0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.050_bib0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.drugalcdep.2015.05.009","article-title":"Discrepancies in addressing overdose prevention through prescription monitoring programs","volume":"153","author":"Green","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.050_bib0075","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1360-0443.2010.02926.x","article-title":"What are the policy lessons of National Alcohol Prohibition in the United States, 1920\u20131933?","volume":"105","author":"Hall","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.050_bib0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2017.03.011","article-title":"Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004\u20132013","volume":"176","author":"Jones","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0085","series-title":"Drug Deaths in America Are Rising Faster Than Ever","author":"Katz","year":"2017"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.050_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08897077.2016.1261070","article-title":"Turning the tide or riptide? The changing opioid epidemic","volume":"38","author":"Kertesz","year":"2017","journal-title":"Substance Abuse Journal"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0095","series-title":"How dry we were: Prohibition revisited","author":"Lee","year":"1963"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0100","series-title":"Drugs and society: US Public Policy","article-title":"Alcohol prohibition and drug prohibition: Lessons from alcohol policy for drug policy","author":"Levine","year":"2005"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0105","article-title":"Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA","author":"Marshall","year":"2017","journal-title":"IJDP"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0110","series-title":"Data Brief: Opioid- Related Overdose Deaths Among Massachusetts Residents","author":"Massachusetts Department of Public Health","year":"2017"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugpo.2016.01.009","article-title":"There\u2019s nothing here: Deindustrialization as risk environment for overdose","volume":"29","author":"McLean","year":"2016","journal-title":"The International Journal on Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.050_bib0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.socscimed.2013.04.009","article-title":"The good-enough science-and-politics of anthropological collaboration with evidence-based clinical research: Four ethnographic case studies","volume":"99","author":"Messac","year":"2013","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0125","series-title":"Alcohol consumption during prohibition. National Bureau of Economic Research","author":"Miron","year":"1991"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0130","series-title":"How the epidemic of drug overdose death ripples across America","author":"Park","year":"2016"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.050_bib0135","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates","volume":"35","author":"Patrick","year":"2016","journal-title":"Health Affairs"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0140","series-title":"Immigration enforcement along U.S. borders and at Ports of entry: Federal, state and local efforts","author":"Pew Charitable Trusts","year":"2016"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0145","series-title":"The legacy of Len Bias: Police treating overdoses as homicides, Fox Channel 6, October 31 2013","author":"Polcyn","year":"2017"},{"issue":"50\u201351","key":"10.1016\/j.drugpo.2017.05.050_bib0150","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.050_bib0155","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida\u2019s Prescription Drug Monitoring Program and Pill Mill Laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.050_bib0160","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"22","key":"10.1016\/j.drugpo.2017.05.050_bib0165","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.05.050_bib0170","series-title":"The economic results of prohibition","author":"Warburton","year":"1968"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T13:51:23Z","timestamp":1569851483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"alternative-id":["S0955395917301548"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.050","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Today\u2019s fentanyl crisis: Prohibition\u2019s Iron Law, revisited","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}